◆ TICKERBASEインタラクティブ表示 →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY
ホーム › 全銘柄 › SAILIFE · English version

Sai Life Sciences Limited (SAILIFE)

公式財務諸表に基づく売上高、利益、キャッシュフローの推移。

Healthcare · ウォール街（米国） · 最終更新: 2026-09-20

Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. It offers medicinal chemistry, pharmacokinetics, clinical and commercial manufacturing, and process development services. The company was formerly known as SAI Advantium Pharma Limited and changed its name to Sai Life Sciences Limited in July 2006. Sai Life Sciences Limited was incorporated in 1999 and is headquartered in Hyderabad, India.

主要指標

インタラクティブチャートと全財務諸表を見る →

年次損益計算書

損益計算書2026-03-312025-03-312024-03-312023-03-31
売上高合計₹21.4B₹16.6B₹14.6B₹12.0B
売上総利益₹8.4B₹6.2B₹4.9B₹3.2B
営業利益（EBIT）₹4.7B₹2.7B₹1.8B₹768M
当期純利益₹3.5B₹1.7B₹828M₹100M

出典: 企業の公開資料（SEC）。数値をご利用の前に SEC EDGAR でご確認ください。

貸借対照表、キャッシュフロー計算書、四半期データおよび全財務比率は SAILIFE のインタラクティブ・ビューアーでご覧いただけます。 /companies/us/SAILIFE

類似企業

本サイトの情報は教育および情報提供のみを目的としており、投資助言ではありません。目標株価や投資判断は掲載していません。

English version →全銘柄

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.